Table of Contents Table of Contents
Previous Page  1421 / 1674 Next Page
Information
Show Menu
Previous Page 1421 / 1674 Next Page
Page Background

Biology and caveats

-predisposing factors for late effects

PATIENT-RELATED PROBLEMS

Age (e.g. heart disease)

Other diseases e.g. rheumatoid arthritis,

systemic lupus erythematosus,

dermatomyositis, systemic sclerosis

Surgical complications

Influence from systemic therapy and the timing

between RT and systemic therapy

Future dream: National (or international) clinical

databanks

TECHNIQUE-RELATED PROBLEMS

Dose, fractionation, hot spots, volume,

fotons

versus

electrons, overall treatment

time

Future dream: National (or international)

doseplan databanks

ENDPOINT-RELATED PROBLEMS

Scoring of late morbidity is subjective, e.g. what is a grade 2

fibrosis?

Different scoring systems are used in different studies

Future dream: We all use the same scoring system, take photos

in a standardised way, evaluate the same endpoints and use the

same cutpoints